BAK(BAK)
BAK
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $78.46B | $79.33B | $83.99B | $63.67B | $68.50B |
| Low | $70.33B | $71.11B | $75.28B | $57.07B | $61.39B |
| High | $86.41B | $87.37B | $92.50B | $70.12B | $75.44B |
| EBITDA Avg | $6.50B | $6.57B | $6.95B | $5.27B | $5.67B |
| Low | $5.82B | $5.89B | $6.23B | $4.73B | $5.08B |
| High | $7.16B | $7.23B | $7.66B | $5.81B | $6.25B |
| EBIT Avg | $2.15B | $2.17B | $2.30B | $1.75B | $1.88B |
| Low | $1.93B | $1.95B | $2.06B | $1.56B | $1.68B |
| High | $2.37B | $2.40B | $2.54B | $1.92B | $2.07B |
| Net Income Avg | $1.10B | $-966M | $614M | $-1.05B | $206M |
| Low | $1.02B | $-2.30B | $531M | $-1.19B | $178M |
| High | $1.17B | $376M | $695M | $-909M | $233M |
| EPS Avg | $2.75 | $-2.42 | $1.54 | $-2.64 | $0.52 |
| Low | $2.56 | $-5.77 | $1.33 | $-2.98 | $0.45 |
| High | $2.93 | $0.94 | $1.74 | $-2.28 | $0.58 |
| Analysts (Rev / EPS) | 4 / 1 | 4 / 1 | 1 / 1 | 2 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $20.79B | $18.75B |
| Low | $20.33B | $18.58B |
| High | $21.24B | $18.91B |
| EBITDA Avg | $1.72B | $1.55B |
| Low | $1.68B | $1.54B |
| High | $1.76B | $1.57B |
| EBIT Avg | $570M | $514M |
| Low | $557M | $509M |
| High | $582M | $518M |
| Net Income Avg | $219M | $-491M |
| Low | $213M | $-505M |
| High | $226M | $-477M |
| EPS Avg | $0.55 | $-1.23 |
| Low | $0.54 | $-1.27 |
| High | $0.57 | $-1.20 |
| Analysts (Rev / EPS) | 1 / 1 | 2 / 1 |